Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug (Q33487352)
scientific article
Language:
Current Data About Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug
(P31) (Q13442814)
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P304) 11-15
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P433) 1
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P478) 5
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P577) Tuesday, January 1, 1980
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P921) (Q5452194)

(P1433) (Q326137)
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P1476) "Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug" (language: en)
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P2093) D S Alberts
(P1545) 1
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

K S Griffith
(P1545) 2
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

G E Goodman
(P1545) 3
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

T S Herman
(P1545) 4
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

E Murray
(P1545) 5
(P248)
(P698) 7460190
(P813) Thursday, July 27, 2017

(P2860) (Q41455616)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

(Q41487334)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

(Q41487142)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

(Q33486828)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

(Q67277924)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

(Q34700624)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/7460190
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article

External Links
(P356) 10.1007/BF00578556
(P698) 7460190
(P6179) 1019285924